Exane Derivatives’s TCF Financial Corporation Common Stock TCF Stock Holding History

Exane Derivatives’s Portfolio TCF Stock Details TCF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,586	Closed	-$352K	–	1098
2021 Q1	$352K	Sell	7,586 -28	-0.4%	-$1.24K	0.1%	193
2020 Q4	$282K	Buy	7,614 +2,596	+52%	+$82.5K	0.08%	255
2020 Q3	$117K	Buy	5,018 +3,581	+249%	+$95.8K	0.03%	283
2020 Q2	$42.3K	Sell	1,437 -4,105	-74%	-$113K	0.01%	363
2020 Q1	$126K	Sell	5,542 -4,061	-42%	-$153K	0.04%	252
2019 Q4	$432K	Buy	+9,603	New	+$398K	0.08%	186

Exane Derivatives's TCF Position: Q2 2021 in Review

Exane Derivatives sold out of TCF Financial Corporation Common Stock (TCF) in Q2 2021, closing a stake of 7,586 shares — an estimated $352K sold.

Exane Derivatives first reported a position in TCF in Q4 2019 and held it in 6 quarters. The position peaked at $432K in Q4 2019. 0 funds tracked by Wall St. Rank hold TCF as of Q2 2021.

Exane Derivatives reported no remaining TCF Financial Corporation Common Stock position as of Q2 2021 after selling out during the quarter.
Exane Derivatives sold 7,586 TCF Financial Corporation Common Stock shares in Q2 2021, an estimated $352K.
Exane Derivatives first reported a position in TCF Financial Corporation Common Stock in Q4 2019 and held it in 6 quarters.
Exane Derivatives's TCF Financial Corporation Common Stock position peaked at $432K in Q4 2019.
0 funds tracked by Wall St. Rank held TCF Financial Corporation Common Stock as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.